Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02237001 · ClinicalTrials.gov registry record · NA
Study of Suture Repair of Torn Meniscus in the Knee
A NA study, sponsored by Smith & Nephew.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02237001: Completed NA study, sponsored by Smith & Nephew.
NCT02237001 is a NA study that has completed, run by Smith & Nephew. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02237001, a NA study, has completed, sponsored by Smith & Nephew.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
Horizontal meniscus tears meeting specified criteria will be repaired by any commonly used suture technique. Subjects will be followed for 2 years to evaluate the effectiveness of the repair, by assessing the re-operation rate, and by assessing improvements in knee pain and knee function.
Primary Outcome
Occurrence of any re-operation of study knee to treat previously repaired meniscal tear during the 2 years following the study procedure.
Interventions
- DEVICE Suture-based meniscal repair
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2014-11-19 |
| Est. Completion | 2019-11-18 |
| Phase | NA |
What the finished NCT02237001 record still lists
NCT02237001 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Suture-based meniscal repair is the first listed.
NCT02237001 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02237001 about?
NCT02237001 is a clinical study titled "Study of Suture Repair of Torn Meniscus in the Knee". Horizontal meniscus tears meeting specified criteria will be repaired by any commonly used suture technique. Subjects will be followed for 2 years to evaluate the effectiveness of the repair, by assessing the re-operation rate, and by assessing improvements in knee pain and knee function.
What is the current status of trial NCT02237001?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2014-11-19. Estimated completion is 2019-11-18.
What interventions are being tested in trial NCT02237001?
The interventions under investigation include: Suture-based meniscal repair (DEVICE).
Who is sponsoring clinical trial NCT02237001?
This trial is sponsored by Smith & Nephew, which has 72 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02237001's enrollment target sits among peer trials
30 1593rd of 2000 higher than 299 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI